Brogie Jackie D, Rumph Joshua H, Chaplin Michelle D, Drake Nicole, Hodge Bryan K, Owens Ryan E
Jackie D. Brogie is a pharmacy student at Wingate University School of Pharmacy, Hendersonville, N.C. Joshua H. Rumph is a pharmacy student at Wingate University School of Pharmacy, Hendersonville, N.C. Michelle D. Chaplin is an associate professor at Wingate University School of Pharmacy, Hendersonville, N.C. Nicole A. Drake is an assistant professor at Wingate University Physician Assistant Program, Hendersonville, N.C. Bryan K. Hodge is a family medicine physician and director of rural health initiatives at Mountain Area Health Education Center, Hendersonville, N.C. Ryan E. Owens is an assistant professor at Wingate University School of Pharmacy; Hendersonville, N.C.
Nurse Pract. 2019 Sep;44(9):43-47. doi: 10.1097/01.NPR.0000574676.64980.7e.
The recombinant zoster vaccine (Shingrix) was approved to help combat the incidence of shingles in patients age 50 years and older and the CDC now recommends it over the zoster vaccine live (Zostavax). This article highlights practical considerations to help clinicians appropriately apply the most recent vaccine recommendations to their patients.
重组带状疱疹疫苗（欣安立适）已获批用于帮助降低50岁及以上患者的带状疱疹发病率，美国疾病控制与预防中心（CDC）现在建议使用该疫苗而非减毒活带状疱疹疫苗（ zostavax ）。本文重点介绍了一些实际注意事项，以帮助临床医生将最新的疫苗建议适当地应用于患者。
